PM360

OCTOBER 22, 2024

A treatment’s impact on utilization of other healthcare services: The effects of a treatment can lead to changes in the utilization of other healthcare products and services, such as hospitalizations, surgeries, or use of other drugs.

Side effects 52

Side effects Patients Prescription Healthcare 52

European Pharmaceutical Review

MARCH 14, 2024

To mark World Kidney Day 2024, Dr Marshall Fordyce, CEO of Vera Therapeutics, spoke with EPR about the challenges of treating kidney diseases, specifically IgAN, a condition caused by dysfunctional B cells. Individuals who receive corticosteroids may experience limited efficacy, alongside significant side effects.

Food and Drug Administration 98

Food and Drug Administration Leads Patients Side effects 98

European Pharmaceutical Review

MARCH 14, 2024

To mark World Kidney Day 2024, Dr Marshall Fordyce, CEO of Vera Therapeutics, spoke with EPR about the challenges of treating kidney diseases, specifically IgAN, a condition caused by dysfunctional B cells. Individuals who receive corticosteroids may experience limited efficacy, alongside significant side effects.

Food and Drug Administration 98

Food and Drug Administration Leads Patients Side effects 98

Pharmaceutical Technology

JUNE 16, 2023

Belgium-headquartered ANeuroTech is participating in a Series B round, which will raise up to $150m to power the pivotal programme of its lead candidate ANT01 for use as an adjunctive treatment for major depressive disorder (MDD). The company aims to run an interim analysis of the trial by mid-2024 at the very latest.

Food and Drug Administration 52

Food and Drug Administration Side effects Safety Recruitment 52

PM360

SEPTEMBER 30, 2024

Toby Katcher SVP, Video Investment, Dept Lead CMI Media Group tkatcher@cmimediagroup.com Building trust equity is crucial, but it’s difficult and full of challenges that might compromise a brand’s credibility and authenticity. Keeping messages consistent across different platforms is another difficulty that can lead to fragmented experiences.

Ethics 59

Ethics Pharma Side effects Healthcare 59

Pharmaceutical Representative Training

OCTOBER 9, 2024

3 By actively listening to providers and addressing their objections with tailored solutions, sales professionals can cultivate strong relationships that lead to success in this competitive field. They may have valid concerns about the product’s cost, potential side effects, or its suitability for their patients.

Sales 52

Sales Pharma Pharmaceutical Sales Prospecting 52

pharmaphorum

JUNE 23, 2022

It is a challenging proposition, however, as delivery of the therapeutic gene sequences to cells can be difficult and raises the risk of insertion mutations that can lead to side effects, including cancer.

Side effects 79

Side effects Pharma Marketing Patients 79

PM360

OCTOBER 22, 2024

stuart.long@infobionic.com SHYAM SAKHRANI Senior Director, Global Offering Lead, Patient Engagement and Support, IQVIA Digital health tools and technologies are gaining acceptance and are being more widely adopted by consumers. Educational materials for patients, both print out and online, have been used to address common side effects.

Education 52

Education Side effects Medical Patients 52

PM360

AUGUST 7, 2024

By identifying biological targets for new drugs and finding potential compounds that interact effectively with the target, new compounds can be developed that enhance effectiveness and reduce side effects. However, it can lead to overutilization of services and may not incentivize quality or outcomes.

Patients 52

Patients Side effects Training Management 52

pharmaphorum

OCTOBER 10, 2022

month mPFS with Keytruda plus chemo, with fewer side effects. A key readout for BMS will be a front-line phase 2 study of its combination in NSCLC due to read out in 2024, but its unclear if that could support approval so Immutep could be able to maintain a lead in this type of cancer.

Side effects 59

Side effects Sales Marketing FDA 59

European Pharmaceutical Review

JULY 18, 2024

1 As they can be highly targeted in their action, they could become the treatment of choice for clinicians and patients due to the reduced risk of side effects. Because ADCs offer a good way to specifically deliver an effective treatment to tumour systems, this could be an improvement on the systemic impact of chemotherapy.

Food and Drug Administration 59

Food and Drug Administration Engineering Pharmacology Side effects 59

European Pharmaceutical Review

AUGUST 3, 2023

However, the EMA expressed concerns around overall efficacy and, coupled with a concern raised over possible side effects presenting as brain abnormalities suggestive of swelling or bleeding on the brain, led the EMA to the view, following a re-examination process, that it would not recommend the approval of Aduhelm.

Food and Drug Administration 52

Food and Drug Administration Medicine FDA Marketing 52

pharmaphorum

JULY 26, 2022

BROADWAY and BOOKLYN will generate data in 2024, with PREVAIL set to read to in 2026, and if the results are positive will be followed by filings in the US, Europe, China and Japan. So why will obicetrapib avoid the pitfalls of its predecessors?

Side effects 52

Side effects Safety Pharma Patients 52

PM360

OCTOBER 22, 2024

And with therapy underway, many of these programs help boost adherence¹ by addressing common barriers to compliance, like missed doses, side effects, and unreliable information about the drug and disease.² They promote access to therapy by helping eligible patients afford their medications.

Patients 59

Patients Healthcare Provider Pharma Prescription 59

PM360

APRIL 22, 2024

Ideally, insights from MSL activities lead to better evidence and more successful development programs and patient outcomes. For example, imagine if a new product in development carries with it transformational efficacy and an uncommon side effect that needs to be carefully managed by a specialty other than the treating specialty.

Education 52

Education Medical Medical science Customer Relationship Management 52

Medico Reach

FEBRUARY 8, 2023

billion during 2020-2024. AI can lead to faster research, combining and extracting data into usable formats, making clinical trials more efficient and saving time. The Emergence of the Pharmacovigilance Market Medicines and vaccines often have unwanted and severe side effects. from 2023 to 2030. billion by 2027.

Pharma 52

Pharma Medicine Marketing Prospecting 52

Pharmaceutical Representative Training

JUNE 22, 2024

Technological advancements, shifting market dynamics, and updated regulations are leading to significant changes within the pharmaceutical industry. Preventing Misuse: Strict regulations are required to stop the improper use and abuse of drugs, especially those that have strong side effects or the potential to become addictive.

Sales 52

Sales Pharmaceutical Ethics Pharmaceutical Sales 52

European Pharmaceutical Review

OCTOBER 3, 2024

Although effective, this approach often results in significant side effects, including increased susceptibility to viral reactivation, infections, and, in some cases, a heightened risk of cancer due to reduced immune surveillance. 2024; 11(3). cited 2024 Oct]. References Fox RJ, Heinz Wiendl, Wolf C, et al.

Safety 52

Safety Pharmaceutical Patients Side effects 52

Evolve Your Success

FEBRUARY 13, 2024

I was thankful and blessed to connect with one of the leading researchers on my subtype. At my age, he was like, “You had such a great response to chemo that you have a higher chance of dealing with major issues and potential fatality from radiation side effects in twenty years versus the cancer coming back.” He’s a great guy.

Patients 64

Patients Sales Medical sales Doctors 64

Pharmaceutical Technology

FEBRUARY 17, 2023

The demand came amid concerns that the drug causes a slew of side effects such as nausea, diarrhea, and liver issues. In 2021, Amgen agreed to conduct a Phase II study (NCT04933695), which is supposed to complete in May 2024, according to Clinicaltrials.gov. What is drug dose optimisation?

FDA 115

FDA Side effects Pharmacology Patients 115

Pharmaceutical Technology

JUNE 20, 2023

GlobalData forecasts that the market for AI platforms for the entire healthcare industry will reach $4.3bn by 2024, up from $1.5bn in 2019 [i]. This additional feedback also leads to improvements to the NMT, to ensure it achieves continuous high-quality translations. This includes assessing content for MT viability, and pilot testing.

Electronics 52

Electronics Medical Healthcare Healthcare 52